Switzerland: Xeltis raises €10.5 million Series D

Zurich-based Xeltis has raised €10.5 million Series D funding led by LSP, Kurma Partners, VI Partners and Ysios. The medtech company has developed restorative pulmonary heart valves and funds raised will be used to develop this technology. “We are very excited about the ongoing support of Xeltis existing investors, following the expansion of our strategy…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »